Bacteriocin production: a relatively unharnessed probiotic trait?

por Hegarty, James W., Guinane, Caitriona M., Ross, R. Paul, Hill, Colin, Cotter, Paul D.
Publicado 2016

Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo

por Murphy, Christopher K, O’Donnell, Michelle M, Hegarty, James W, Schulz, Sarah, Hill, Colin, Ross, R Paul, Rea, Mary C, Farquhar, Ronald, Chesnel, Laurent
Publicado 2023

First evidence of production of the lantibiotic nisin P

por Garcia-Gutierrez, Enriqueta, O’Connor, Paula M., Saalbach, Gerhard, Walsh, Calum J., Hegarty, James W., Guinane, Caitriona M., Mayer, Melinda J., Narbad, Arjan, Cotter, Paul D.
Publicado 2020

Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities

por O’Donnell, Michelle M., Hegarty, James W., Healy, Brian, Schulz, Sarah, Walsh, Calum J., Hill, Colin, Ross, R. Paul, Rea, Mary C., Farquhar, Ronald, Chesnel, Laurent
Publicado 2022